{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:51:19Z","timestamp":1782881479703,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1053\/j.ackd.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T02:37:16Z","timestamp":1366943836000},"page":"271-279","source":"Crossref","is-referenced-by-count":49,"title":["Emerging New Biomarkers of Preeclampsia"],"prefix":"10.1053","volume":"20","author":[{"given":"Srujana","family":"Polsani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Jim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9516","key":"10.1053\/j.ackd.2013.01.001_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0002-9378(00)24793-5","article-title":"Association of preeclampsia with high birth weight for age","volume":"183","author":"Xiong","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/0002-9378(95)91412-9","article-title":"Neonatal outcome after preterm delivery for preeclampsia","volume":"172","author":"Friedman","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1053\/j.ackd.2013.01.001_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/adc.88.8.726","article-title":"Pre-eclampsia and febrile convulsions","volume":"88","author":"Vestergaard","year":"2003","journal-title":"Arch Dis Childhood"},{"issue":"7627","key":"10.1053\/j.ackd.2013.01.001_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"issue":"8","key":"10.1053\/j.ackd.2013.01.001_bib6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and the risk of end-stage renal disease","volume":"359","author":"Vikse","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib7","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ajog.2004.02.037","article-title":"Delayed postpartum preeclampsia: an experience of 151 cases","volume":"190","author":"Matthys","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.ackd.2013.01.001_bib8","unstructured":"Khalil A, Rezende J, Akolekar R, Syngelaki A, Nicolaides KH. Maternal racial origin and adverse pregnancy outcomes: a cohort study. Ultrasound Obstet Gynecol. doi:10.1002\/uog.12313.2012."},{"issue":"12","key":"10.1053\/j.ackd.2013.01.001_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM200103223441201","article-title":"Paternal and maternal components of the predisposition to preeclampsia","volume":"344","author":"Esplin","year":"2001","journal-title":"N Engl J Med"},{"issue":"8928","key":"10.1053\/j.ackd.2013.01.001_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(94)91638-1","article-title":"Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception","volume":"344","author":"Robillard","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa011379","article-title":"The interval between pregnancies and the risk of preeclampsia","volume":"346","author":"Skjaerven","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2013.01.001_bib12","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2741\/2248","article-title":"Smoking and risk of preeclampsia: a systematic review","volume":"12","author":"England","year":"2007","journal-title":"Front Biosci"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib13","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.ajog.2007.06.025","article-title":"Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke","volume":"197","author":"Mehendale","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-0528.2008.01702.x","article-title":"Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands","volume":"115","author":"Schutte","year":"2008","journal-title":"BJOG"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/187152510792481234","article-title":"Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia","volume":"8","author":"Reslan","year":"2010","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"10","key":"10.1053\/j.ackd.2013.01.001_bib16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.ackd.2013.01.001_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib19","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0029-7844(01)01341-2","article-title":"Decreased maternal serum placenta growth factor in early second\u00a0trimester and preeclampsia","volume":"97","author":"Su","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0029-7844(01)01497-1","article-title":"Plasma placenta growth factor levels in midtrimester pregnancies","volume":"98","author":"Tjoa","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0029-7844(03)00338-7","article-title":"Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia","volume":"101","author":"Polliotti","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1053\/j.ackd.2013.01.001_bib23","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","article-title":"Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia","volume":"50","author":"Hertig","year":"2004","journal-title":"Clin Chem"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1081\/PRG-120028286","article-title":"Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia","volume":"23","author":"Krauss","year":"2004","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0412.2004.00277.x","article-title":"Second- and third-trimester serum\u00a0levels of placental proteins in preeclampsia and small-for-gestational age pregnancies","volume":"83","author":"Bersinger","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3 Pt 2","key":"10.1053\/j.ackd.2013.01.001_bib26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajog.2005.06.033","article-title":"An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia","volume":"193","author":"Park","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib27","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.ackd.2013.01.001_bib29","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.ajog.2010.08.049","article-title":"Circulating angiogenic and antiangiogenic factors in women with eclampsia","volume":"204","author":"Vaisbuch","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.109.895458","article-title":"Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension","volume":"122","author":"Noori","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ackd.2013.01.001_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajog.2005.10.192","article-title":"Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women","volume":"194","author":"Levine","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1053\/j.ackd.2013.01.001_bib34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/00016340802253759","article-title":"Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia","volume":"87","author":"De Vivo","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1053\/j.ackd.2013.01.001_bib35","doi-asserted-by":"crossref","first-page":"407.e1","DOI":"10.1016\/j.ajog.2012.08.010","article-title":"Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy","volume":"207","author":"McElrath","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib36","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.ajog.2009.07.025","article-title":"Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study","volume":"202","author":"Sunderji","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1053\/j.ackd.2013.01.001_bib37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.ki.5000075","article-title":"Low urinary placental growth factor is a marker of pre-eclampsia","volume":"69","author":"Aggarwal","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-0528.2008.02074.x","article-title":"First trimester urinary placental growth factor and development of pre-eclampsia","volume":"116","author":"Savvidou","year":"2009","journal-title":"BJOG"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1471-0528.2009.02434.x","article-title":"The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio","volume":"117","author":"Buhimschi","year":"2010","journal-title":"BJOG"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ki.2012.348","article-title":"Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers","volume":"83","author":"Rolfo","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000339935","article-title":"Superimposed preeclampsia in women with chronic kidney disease","volume":"74","author":"Masuyama","year":"2012","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1053\/j.ackd.2013.01.001_bib44","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.ajog.2007.02.025","article-title":"First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction","volume":"197","author":"Chafetz","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000151344","article-title":"Longitudinal determination of serum placental protein 13 during development of preeclampsia","volume":"24","author":"Huppertz","year":"2008","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"10.1053\/j.ackd.2013.01.001_bib46","doi-asserted-by":"crossref","first-page":"122.e1","DOI":"10.1016\/j.ajog.2008.01.013","article-title":"First-trimester maternal serum PP13 in the risk assessment for preeclampsia","volume":"199","author":"Romero","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/10641955.2010.484081","article-title":"Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes","volume":"30","author":"Stamatopoulou","year":"2011","journal-title":"Hypertens Pregnancy"},{"issue":"12","key":"10.1053\/j.ackd.2013.01.001_bib48","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pd.2375","article-title":"Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenatal Diagn"},{"issue":"8","key":"10.1053\/j.ackd.2013.01.001_bib49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","article-title":"First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0028-2243(88)90014-7","article-title":"Doppler ultrasound of the uteroplacental circulation as a screening test for severe pre-eclampsia with intra-uterine growth retardation","volume":"28","author":"Steel","year":"1988","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"10.1053\/j.ackd.2013.01.001_bib51","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1469-0705.2000.00289.x","article-title":"Quantification of the diastolic notch in Doppler ultrasound screening of uterine arteries","volume":"16","author":"Aardema","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.ackd.2013.01.001_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/GCO.0b013e32809bd964","article-title":"Uterine artery Doppler in the prediction of adverse pregnancy outcome","volume":"19","author":"Papageorghiou","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib53","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"issue":"2 Pt 1","key":"10.1053\/j.ackd.2013.01.001_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/AOG.0b013e3181801d56","article-title":"Prediction and prevention of recurrent preeclampsia","volume":"112","author":"Barton","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib57","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib59","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/ndt\/gfl711","article-title":"Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia","volume":"22","author":"Garovic","year":"2007","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"10.1053\/j.ackd.2013.01.001_bib60","doi-asserted-by":"crossref","first-page":"320.e1","DOI":"10.1016\/j.ajog.2007.02.007","article-title":"Urinary podocyte excretion as a marker for preeclampsia","volume":"196","author":"Garovic","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1053\/j.ackd.2013.01.001_bib61","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1177\/1933719109338630","article-title":"Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia","volume":"16","author":"Zhao","year":"2009","journal-title":"Reprod Sci"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib62","doi-asserted-by":"crossref","first-page":"F1185","DOI":"10.1152\/ajprenal.00442.2007","article-title":"Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells","volume":"294","author":"Collino","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1053\/j.ackd.2013.01.001_bib63","doi-asserted-by":"crossref","first-page":"c65","DOI":"10.1159\/000213083","article-title":"Acute and transient podocyte loss and proteinuria in preeclampsia","volume":"112","author":"Aita","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ackd.2013.01.001_bib64","first-page":"984630","article-title":"Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients","volume":"2012","author":"Jim","year":"2012","journal-title":"J\u00a0Pregnancy"},{"issue":"9","key":"10.1053\/j.ackd.2013.01.001_bib65","doi-asserted-by":"crossref","first-page":"F1084","DOI":"10.1152\/ajprenal.00597.2011","article-title":"Increased urinary excretion of nephrin, podocalyxin, and betaig-h3 in women with preeclampsia","volume":"302","author":"Wang","year":"2012","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1053\/j.ackd.2013.01.001_bib66","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/HYPERTENSIONAHA.112.201681","article-title":"Quantitative polymerase chain reaction-based analysis of podocyturia is a feasible diagnostic tool in preeclampsia","volume":"60","author":"Kelder","year":"2012","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib67","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.semnephrol.2010.07.002","article-title":"Integrative systems biology for data-driven knowledge discovery","volume":"30","author":"Greene","year":"2010","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2013.01.001_bib68","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1503\/cmaj.061590","article-title":"Urine proteomics: the present and future of measuring urinary protein components in disease","volume":"177","author":"Barratt","year":"2007","journal-title":"CMAJ"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib69","doi-asserted-by":"crossref","first-page":"551.e1","DOI":"10.1016\/j.ajog.2008.07.006","article-title":"Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia","volume":"199","author":"Buhimschi","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1203\/00006450-199309000-00015","article-title":"Synthesis of alpha 1-antichymotrypsin and alpha 1-antitrypsin by human trophoblast","volume":"34","author":"Bergman","year":"1993","journal-title":"Pediatr Res"},{"key":"10.1053\/j.ackd.2013.01.001_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0463.2012.02936.x","article-title":"Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease","volume":"121","author":"Linja-Aho","year":"2013","journal-title":"APMIS"},{"issue":"12","key":"10.1053\/j.ackd.2013.01.001_bib72","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.ATV.0000041842.43905.F3","article-title":"Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins","volume":"22","author":"Engstrom","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5-6","key":"10.1053\/j.ackd.2013.01.001_bib73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/prca.201000100","article-title":"Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS\/MS","volume":"5","author":"Chen","year":"2011","journal-title":"Proteomics Clin Appl"},{"issue":"3","key":"10.1053\/j.ackd.2013.01.001_bib74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/HYPERTENSIONAHA.110.164285","article-title":"Urinary proteomics for prediction of preeclampsia","volume":"57","author":"Carty","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib75","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ng.377","article-title":"Multiple loci associated with indices of renal function and chronic kidney disease","volume":"41","author":"Kottgen","year":"2009","journal-title":"Nat Genet"},{"key":"10.1053\/j.ackd.2013.01.001_bib76","doi-asserted-by":"crossref","first-page":"D603","DOI":"10.1093\/nar\/gkn810","article-title":"HMDB: a knowledgebase for the human metabolome","volume":"37","author":"Wishart","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1053\/j.ackd.2013.01.001_bib77","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/pd.2822","article-title":"First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study","volume":"31","author":"Odibo","year":"2011","journal-title":"Prenatal Diagn"},{"issue":"10","key":"10.1053\/j.ackd.2013.01.001_bib78","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3109\/14767058.2012.680254","article-title":"Metabolomics and first-trimester prediction of early-onset preeclampsia","volume":"25","author":"Bahado-Singh","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"8","key":"10.1053\/j.ackd.2013.01.001_bib79","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"issue":"7491","key":"10.1053\/j.ackd.2013.01.001_bib80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1053\/j.ackd.2013.01.001_bib81","first-page":"253","article-title":"Toxemia of pregnancy in Jerusalem. I. Epidemiological studies of a total community","volume":"6","author":"Davies","year":"1970","journal-title":"Isr J Med Sci"},{"issue":"7","key":"10.1053\/j.ackd.2013.01.001_bib82","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"BJOG"},{"issue":"5","key":"10.1053\/j.ackd.2013.01.001_bib83","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.2217","article-title":"Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia","volume":"29","author":"Lim","year":"2009","journal-title":"Prenatal Diagn"},{"issue":"2","key":"10.1053\/j.ackd.2013.01.001_bib84","doi-asserted-by":"crossref","first-page":"175.e1","DOI":"10.1016\/j.ajog.2007.08.052","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.ackd.2013.01.001_bib85","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1067\/mob.2001.113129","article-title":"Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia","volume":"184","author":"Tidwell","year":"2001","journal-title":"Am J Obstet Gynecol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559513000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559513000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T10:21:30Z","timestamp":1539685290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559513000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1548559513000025"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2013.01.001","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}